Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Newling

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
European Urology|January 1, 1995
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostateM R Robinson, P H Smith, B Richards, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Quality control of radical prostatectomy: a feasibility studyH Van Poppel, L Collette, Z Kirkali, et al.
British Journal of Urology|March 1, 1987
Intravesical mitomycin C for the treatment of recurrent superficial bladder tumoursJ W Hetherington, D W Newling, M R Robinson, et al.
British Journal of Urology|December 1, 1984
Treatment of invasive bladder cancer by local resection and high dose methotrexateR R Hall, D W Newling, P D Ramsden, et al.
Urology|April 1, 1997
Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladderC L Berendsen, W H Peters, P G Scheffer, et al.
British Journal of Urology|December 1, 1983
A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancerG S Harrison, D F Green, D W Newling, et al.
The Journal of Urology|December 1, 1993
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)D W Newling, S D Fossa, U W Tunn, et al.
Histopathology|January 1, 1996
Primary signet-ring cell carcinoma of the urinary bladderR Torenbeek, R A Koot, C E Blomjous, et al.
British Journal of Urology|December 1, 1986
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)J K Siddall, J W Hetherington, E H Cooper, et al.
European Urology|January 1, 1995
Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative GroupD W Newling, M R Robinson, P H Smith, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
European Urology|January 1, 1995
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostateM R Robinson, P H Smith, B Richards, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Quality control of radical prostatectomy: a feasibility studyH Van Poppel, L Collette, Z Kirkali, et al.
British Journal of Urology|March 1, 1987
Intravesical mitomycin C for the treatment of recurrent superficial bladder tumoursJ W Hetherington, D W Newling, M R Robinson, et al.
British Journal of Urology|December 1, 1984
Treatment of invasive bladder cancer by local resection and high dose methotrexateR R Hall, D W Newling, P D Ramsden, et al.
Urology|April 1, 1997
Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladderC L Berendsen, W H Peters, P G Scheffer, et al.
British Journal of Urology|December 1, 1983
A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancerG S Harrison, D F Green, D W Newling, et al.
The Journal of Urology|December 1, 1993
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)D W Newling, S D Fossa, U W Tunn, et al.
Histopathology|January 1, 1996
Primary signet-ring cell carcinoma of the urinary bladderR Torenbeek, R A Koot, C E Blomjous, et al.
British Journal of Urology|December 1, 1986
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)J K Siddall, J W Hetherington, E H Cooper, et al.
European Urology|January 1, 1995
Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative GroupD W Newling, M R Robinson, P H Smith, et al.
Pageof 11